nimbin has been researched along with alloxan in 1 studies
| Studies (nimbin) | Trials (nimbin) | Recent Studies (post-2010) (nimbin) | Studies (alloxan) | Trials (alloxan) | Recent Studies (post-2010) (alloxan) |
|---|---|---|---|---|---|
| 25 | 0 | 13 | 3,259 | 6 | 560 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arockiaraj, J; Bhuvanesh, N; Gopinath, P; Guru, A; Haridevamuthu, B; Juliet, A; Mahboob, S; Murugan, R; Rajesh, R; Sudhakaran, G; Wadaan, MA | 1 |
1 other study(ies) available for nimbin and alloxan
| Article | Year |
|---|---|
Deacetylated nimbin analog N2 fortifies alloxan-induced pancreatic β-cell damage in insulin-resistant zebrafish larvae by upregulating phosphoenolpyruvate carboxykinase (PEPCK) and insulin levels.
Topics: Alloxan; Animals; Antioxidants; Glucose; Glutathione; Hypoglycemic Agents; Insulin; Larva; Limonins; Phosphoenolpyruvate; Phosphoenolpyruvate Carboxykinase (ATP); Reactive Oxygen Species; RNA, Messenger; Zebrafish | 2022 |